Literature DB >> 5032529

Metabolism of steroid and amino acid moieties of conjugated bile acids in man. I. Cholylglycine.

G W Hepner, A F Hofmann, P J Thomas.   

Abstract

Cholyl-2,4-(3)H-glycine-1-(14)C was administered orally to eight healthy subjects with indwelling nasoduodenal tubes. The distribution of radioactivity among bile acids and the specific activity of cholylglycine were determined in bile collected at intervals for 7 days. (3)H and (14)C were measured in stool. (14)C in breath was calculated from interval (14)CO(2) specific activity determinations. The daily fractional turnover of the glycine moiety (mean +/-SE, 106+/-17%) was three times greater than that of the cholyl moiety (38+/-7%). On the basis of certain assumptions, it was calculated that about 18% of the cholylglycine pool was deconjugated per enterohepatic cycle. The extent of deconjugation appeared to be unrelated to the efficiency of absorption of the cholyl moiety, which averaged 90-95% per enterohepatic cycle. (14)C was recovered predominantly in breath (52+/-5% of administered dose), and 24 hr (14)CO(2) excretion correlated highly (r = 0.95) with daily fractional turnover of the glycine moiety. (3)H excretion occurred predominantly in feces, and the rate correlated highly (r = 0.92) with the daily fractional turnover of the cholyl moiety. Deoxycholylglycine became labeled with (3)H rapidly, indicating the occurrence of bacterial 7-dehydroxylation of the cholyl moiety and absorption of deoxycholic acid. This biotransformation occurred in all eight subjects but varied in degree and was unrelated to the degree of deconjugation. Since ingested glycine-1-(14)C was not incorporated into bile acid glycine, appearance of (14)C in deoxycholylglycine (observed in three of eight subjects) indicated that 7-dehydroxylation of cholylglycine can occur without deconjugation. Dehydroxylation was also observed in vitro when fecal homogenates were incubated with cholylglycine.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5032529      PMCID: PMC292337          DOI: 10.1172/JCI106991

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  Bile-salts in small intestinal contents after ileal resection and in other malabsorption syndromes.

Authors:  G M McLeod; H S Wiggins
Journal:  Lancet       Date:  1968-04-27       Impact factor: 79.321

2.  Hyperglycinemia: a defect in glycine cleavage reaction.

Authors:  K Tada; K Narisawa; T Yoshida; T Konno; Y Yokoyama
Journal:  Tohoku J Exp Med       Date:  1969-07       Impact factor: 1.848

3.  Measurement of intestinal fat absorption with carbon-14 labeled tracers.

Authors:  S Kaihara; H N Wagner
Journal:  J Lab Clin Med       Date:  1968-03

4.  Enterohepatic circulation of C14-labeled bile salts in disorders of the distal small bowel.

Authors:  K W Heaton; W I Austad; L Lack; M P Tyor
Journal:  Gastroenterology       Date:  1968-07       Impact factor: 22.682

5.  Metabolism of glycine in the nonketotic form of hyperglycinemia.

Authors:  T Ando; W L Nyhan; T Gerritsen; L Gong; D C Heiner; P F Bray
Journal:  Pediatr Res       Date:  1968-07       Impact factor: 3.756

6.  Comparative utilization of glycine-N15 administered orally or parenterally.

Authors:  O H Gaebler; H C Choitz
Journal:  Metabolism       Date:  1969-05       Impact factor: 8.694

7.  An automatic zonal scraper and sample collector for radioassay of thin-layer chromatograms.

Authors:  F Snyder; H Kimble
Journal:  Anal Biochem       Date:  1965-06       Impact factor: 3.365

8.  A physicochemical approach to the intraluminal phase of fat absorption.

Authors:  A F Hofmann
Journal:  Gastroenterology       Date:  1966-01       Impact factor: 22.682

9.  Glycine metabolism. I. Properties of the system catalyzing the exchange of bicarbonate with the carboxyl group of glycine in Peptococcus glycinophilus.

Authors:  S M Klein; R D Sagers
Journal:  J Biol Chem       Date:  1966-01-10       Impact factor: 5.157

10.  Rapid preparation of tritium-labeled bile acids by enolic exchange on basic alumina containing tritiated water.

Authors:  A F Hofmann; P A Szczepanik; P D Klein
Journal:  J Lipid Res       Date:  1968-11       Impact factor: 5.922

View more
  13 in total

Review 1.  Breath-analysis tests in gastroenterology.

Authors:  A Newman
Journal:  Gut       Date:  1974-04       Impact factor: 23.059

Review 2.  Deoxycholic acid and the pathogenesis of gall stones.

Authors:  S N Marcus; K W Heaton
Journal:  Gut       Date:  1988-04       Impact factor: 23.059

Review 3.  14CO2 in breath.

Authors:  J L Rabinowitz; V Lopez-Majano
Journal:  Eur J Nucl Med       Date:  1981

4.  Effect of conjugated dihydroxy bile salts on electrolyte transport in rat colon.

Authors:  H J Binder; C L Rawlins
Journal:  J Clin Invest       Date:  1973-06       Impact factor: 14.808

5.  Alteration of bile salt metabolism by dietary fibre (bran).

Authors:  E W Pomare; K W Heaton
Journal:  Br Med J       Date:  1973-11-03

6.  Biliary lipid output during three meals and an overnight fast. I. Relationship to bile acid pool size and cholesterol saturation of bile in gallstone and control subjects.

Authors:  T C Northfield; A F Hofmann
Journal:  Gut       Date:  1975-01       Impact factor: 23.059

7.  Metabolism of steroid and amino acid moieties of conjugated bile acids in man. 3. Cholyltaurine (taurocholic acid).

Authors:  G W Hepner; J A Sturman; A F Hofmann; P J Thomas
Journal:  J Clin Invest       Date:  1973-02       Impact factor: 14.808

8.  Regulation of bile salt pool size in man.

Authors:  T S Low-Beer; E W Pomare
Journal:  Br Med J       Date:  1973-05-12

9.  Description and simulation of a physiological pharmacokinetic model for the metabolism and enterohepatic circulation of bile acids in man. Cholic acid in healthy man.

Authors:  A F Hofmann; G Molino; M Milanese; G Belforte
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

10.  Intestinal involvement in progressive systemic sclerosis detected by increased unconjugated serum bile acids.

Authors:  F Stellaard; T Sauerbruch; C H Luderschmidt; B Leisner; G Paumgartner
Journal:  Gut       Date:  1987-04       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.